AppLovin enters the week of July 13 with an uncomfortable split personality: shorts are quietly covering, the borrow market is relaxed, and the Street remains broadly bullish — yet the stock just shed 15% in a single week, trading at $448.98.
The week's most striking data point is that short sellers have been running away from the trade as the stock fell. Short interest dropped nearly 10% on the week to 3.85% of the free float — roughly 11.8 million shares — after running above 13 million for most of June. That is a meaningful covering wave, not a rounding error. The borrow market tells the same story: cost to borrow is running at just 0.46%, a 30-day low, and availability is extraordinarily loose at over 2,000% — meaning more than twenty shares are available to lend for every one already borrowed. The ORTEX short score has eased to 37.4, drifting lower across the past two weeks as short pressure dissipates. Far from a crowded short, the positioning picture looks more like shorts were already offside on the move down and trimming as the stock fell.
Options tell a slightly different story. The put/call ratio climbed to 0.83 on July 14 — above its 20-day average of 0.80 and about 1.2 standard deviations elevated. That places it in the upper half of its 52-week range, but well below the annual high of 0.92. Traders are buying marginally more downside protection than usual, but not with the urgency that would signal real panic. Taken together, the positioning setup looks cautious rather than alarmed: shorts covering into weakness while options buyers hedge modestly against further downside.
The Street is considerably more constructive than current price levels suggest. The consensus mean price target is $654.60 against a close of $448.98 — implying roughly 46% upside from here — though that gap warrants scrutiny given the stock's recent slide. The most recent analyst action, Wells Fargo lifting its target to $575 while holding Overweight on July 7, adds a data point from within the past two weeks. Raymond James launched coverage with a Strong Buy and $640 target in late June. The broader analyst cluster — Citigroup, Needham, UBS, Macquarie, Piper Sandler — is overwhelmingly positive, with JP Morgan's Neutral the clearest dissent and the lowest published target at $515. The bull case rests on AppLovin's AXON ad engine, a projected 51% revenue growth midpoint in Q1, and a 9% e-commerce revenue uplift that bulls argue can reduce the company's dependence on core gaming. Bears point to that same gaming concentration risk, skepticism about AXON's opaque mechanics, and margin sustainability as growth mix shifts. The analyst recommendation divergence factor ranks in the 94th percentile of the ORTEX universe — an unusually wide spread of opinion even by ad-tech standards.
Institutional ownership offers a small counterweight to the seller narrative. Capital Research and Management added 3.7 million shares in the most recent quarter to hold 2.6% of the company. FMR (Fidelity) added 2.6 million shares. BlackRock and State Street added modestly. Founder and CEO Adam Foroughi holds 10.9% — a trim of just 118,000 shares last reported — and no major insider selling has occurred at scale. The recent director sales by Maynard Webb on July 6 total roughly $1.5 million across multiple tranches but score a significance of just 2 out of 10, a routine disposal rather than a signal trade. The 90-day net insider position is actually positive at roughly 117,000 net shares, worth around $59 million — suggesting the insider picture remains broadly supportive even as the stock has corrected.
The next earnings event is scheduled for August 5. The prior two prints landed very differently: Q1 2026 results triggered a 7.7% drop on the day and an 18.6% slide over the following week, while the May 2026 report sparked a 4.3% gain the next session before fading 5% over five days. Those reactions illustrate how binary the stock has become around earnings — a name that can move double digits in either direction depending on whether the AXON and e-commerce narratives hold up under scrutiny. With the stock now trading at a roughly 30% discount to the analyst consensus and a price-to-earnings multiple of about 29x forward, the August 5 print becomes a test of whether the Street's $654 midpoint target reflects a realistic growth path or needs another round of resets.
See the live data behind this article on ORTEX.
Open APP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
